Scarica l'app Stockscreener
17.89
2.23%
0.39
Precedente Chiudi:
$17.50
Aprire:
$17.875
Volume 24 ore:
235.34K
Relative Volume:
0.75
Capitalizzazione di mercato:
$607.56M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+6.42%
1M Prestazione:
+13.44%
6M Prestazione:
-40.84%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$17.75
$18.14
Intervallo di 1 settimana:
$16.40
$18.14
Portata 52W:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Nome
Ceribell Inc
Settore
Industria
Telefono
(800) 436-0826
Indirizzo
360 N. PASTORIA AVENUE, SUNNYVALE
Confronta CBLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
17.89 | 607.56M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-11-05 | Iniziato | BofA Securities | Buy |
| 2024-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Ceribell Inc Borsa (CBLL) Ultime notizie
Nuveen Asset Management LLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell CEO Chao Xingjuan sells $425,000 in stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $425,000 in stock - Investing.com
Ameriprise Financial Inc. Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
BNP Paribas Financial Markets Invests $43,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strategic Growth and Profitability Amidst Market Challenges - TipRanks
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys Shares of 6,957 CeriBell (NASDAQ:CBLL) - Defense World
The medtech IPO window is finally open. Or is it? - MedTech Dive
CeriBell (NASDAQ:CBLL) Receives $32.50 Average Price Target from Brokerages - Defense World
Northern Trust Corp Invests $2.66 Million in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strong Q1 Performance and Promising Growth Justify Buy Rating - TipRanks
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Ceribell CEO Chao Xingjuan sells $424,000 in stock - Investing.com Australia
Ceribell CEO Chao Xingjuan sells $424,000 in stock By Investing.com - Investing.com South Africa
Tower Research Capital LLC TRC Takes $37,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
Ceribell stock holds $36 target amid US-China trade deal hopes By Investing.com - Investing.com South Africa
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com Nigeria
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Reports Strong Q1 2025 Growth - TipRanks
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Inc Azioni (CBLL) Dati Finanziari
Non sono disponibili dati finanziari per Ceribell Inc (CBLL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Ceribell Inc Azioni (CBLL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Jun 03 '25 |
Sale |
17.00 |
25,000 |
425,000 |
776,022 |
0.56%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):